Search
New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
Our People
Our faculty researchers have deep expertise in operations management, organizational behavior, system dynamics, accounting, marketing, and finance.
About Us
HSI's mission is to improve health by discovering transformative and sustainable innovations through research and education with leaders in the field.
Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
Using data science to forecast clinical trial outcomes
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
Finance at MIT Ecosystem
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
MIT LFE and Informa Pharma Intelligence launch Project ALPHA
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
MIT Sloan announces collaboration with Staten Island PPS to drive change in healthcare
By
MIT Sloan School of Management’s Initiative for Health Systems Innovation (HSI) recently announced a formal collaboration with the Staten Island Performing Provider System (SI PPS).
Our Work
Our more than 30 researchers are leading groundbreaking projects that span three main areas: Healthcare Analytics, Healthcare Operations, and Healthcare Incentives